Substance / Medication

Phenoxybenzamine

Overview

Active Ingredient
phenoxybenzamine
RxNorm CUI
8149

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

3 trials linked to this intervention

3
Total Trials
2
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Functional and safety outcomes after benign prostatic enlargement surgeries in men with detrusor underactivity compared with normal detrusor contractility: Systematic review and meta-analysis.
Wroclawski Marcelo Langer, Takemura Lucas Seiti, Santos Hugo Octaviano Duarte et al. · Neurourol Urodyn · 2024
PMID: 38010924Meta-Analysis
Efficacy of transurethral botulinum toxin A injections for bladder outlet obstruction: A systematic review and meta-analysis.
Gavi Filippo, Ragonese Mauro, Fettucciari Daniele et al. · Urologia · 2024
PMID: 38372240Meta-Analysis
The MicroRNAs (miRNAs) Expression in Benign Urological Diseases: A Systematic Review.
Atayi Morteza, Mahdavi Nasim, Salehi-Pourmehr Hanieh et al. · Urol J · 2024
PMID: 38733231Meta-Analysis
The bladder contractility and bladder outlet obstruction indices in adult men: Results of a global Delphi consensus study.
Sinha Sanjay, Finazzi-Agrò Enrico, Dmochowski Roger Roman et al. · Neurourol Urodyn · 2023
PMID: 36273413Meta-Analysis
Effect of bladder outlet procedures on urodynamic assessments in men with an acontractile or underactive detrusor: A systematic review and meta-analysis.
van Merode Nadine A M, Nijholt Ingrid M, Heesakkers John P et al. · Neurourol Urodyn · 2023
PMID: 37498009Meta-Analysis
Alpha-adrenoreceptor blockade with phenoxybenzamine does not affect the ability of the nose to condition air.
Pinto Jayant M, Assanasen Paraya, Baroody Fuad M et al. · J Appl Physiol (1985) · 2005
PMID: 15746297Trial
[Prevention and release of epidural-morphine-induced urinary retention with phenoxybenzamine and neostigmine].
Tang J, Xu Q, Ye T · Zhongguo Yi Xue Ke Xue Yuan Xue Bao · 2000
PMID: 12903414Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Phenoxybenzamine (substance)
SNOMED CT
372838003
UMLS CUI
C0031441
RxNorm CUI
8149

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
3
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.